Artificial Tears And Therapeutic Uses

Patent No. EP2437762 (titled "Artificial Tears And Therapeutic Uses") was filed by Allergan on Jun 3, 2010. The application was issued on Aug 9, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JOHNSON & JOHNSON VISION CAREMay 4, 2018CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2437762

ALLERGAN
Application Number
EP10724631A
Filing Date
Jun 3, 2010
Status
Revoked
Jul 7, 2023
Publication Date
Aug 9, 2017